Gamal El-Din A Abuo-Rahma

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Topics

Molecular Docking

Structure Activity Relationship

Top Venues

Archiv der Pharmazie

Future medicinal chemistry

Molecular diversity

This page only lists publications with an associated author ORCID identifier.

Publications

Donia G Darwish, Hany A M El-Sherief, Salah A Abdel-Aziz, Gamal El-Din A Abuo-Rahma
A decade's overview of 2-aminothiophenes and their fused analogs as promising anticancer agents. Archiv der Pharmazie 357 (6) (2024)
Mona S El-Zoghbi, Amr Ka Bass, Gamal El-Din A Abuo-Rahma, Mamdouh F A Mohamed, Mohamed Badr, Hanan A Al-Ghulikah, El Shimaa M N Abdelhafez
Design, synthesis and mechanistic study of new dual targeting HDAC/tubulin inhibitors. Future medicinal chemistry 16 (7) (2024)
Mona S El-Zoghbi, Amr Ka Bass, Gamal El-Din A Abuo-Rahma, Mamdouh F A Mohamed, Mohamed Badr, Hanan A Al-Ghulikah, El Shimaa M N Abdelhafez
Design, synthesis and mechanistic study of new dual targeting HDAC/tubulin inhibitors. Future medicinal chemistry 16 (7) (2024)
Mona S El-Zoghbi, Amr Ka Bass, Gamal El-Din A Abuo-Rahma, Mamdouh F A Mohamed, Mohamed Badr, Hanan A Al-Ghulikah, El Shimaa M N Abdelhafez
Design, synthesis and mechanistic study of new dual targeting HDAC/tubulin inhibitors. Future medicinal chemistry 16 (7) (2024)
Donia G Darwish, Hany A M El-Sherief, Salah A Abdel-Aziz, Gamal El-Din A Abuo-Rahma
A decade's overview of 2-aminothiophenes and their fused analogs as promising anticancer agents. Archiv der Pharmazie (2024)
Mona S El-Zoghbi, Amr Ka Bass, Gamal El-Din A Abuo-Rahma, Mamdouh F A Mohamed, Mohamed Badr, Hanan A Al-Ghulikah, El Shimaa M N Abdelhafez
Design, synthesis and mechanistic study of new dual targeting HDAC/tubulin inhibitors. Future medicinal chemistry (2024)
Donia G Darwish, Hany A M El-Sherief, Salah A Abdel-Aziz, Gamal El-Din A Abuo-Rahma
A decade's overview of 2-aminothiophenes and their fused analogs as promising anticancer agents. Archiv der Pharmazie 357 (6) (2024)
Gamal El-Din A Abuo-Rahma, Mamdouh F A Mohamed, Tarek S Ibrahim, Mai E Shoman, Ebtihal Samir, Rehab M Abd El-Baky
Potential repurposed SARS-CoV-2 (COVID-19) infection drugs. RSC advances 10 (45) (2020)
Hossameldin A Aziz, Gamal A I Moustafa, Gamal El-Din A Abuo-Rahma, Safwat M Rabea, Glenn Hauk, Vagolu S Krishna, Dharmarajan Sriram, James M Berger, Samar H Abbas
Synthesis and antimicrobial evaluation of new nitric oxide-donating fluoroquinolone/oxime hybrids. Archiv der Pharmazie 354 (1) (2020)
Mohammed A I Elbastawesy, Yaseen A M M El-Shaier, Mohamed Ramadan, Alan B Brown, Ashraf A Aly, Gamal El-Din A Abuo-Rahma
Identification and molecular modeling of new quinolin-2-one thiosemicarbazide scaffold with antimicrobial urease inhibitory activity. Molecular diversity 25 (1) (2020)
Mamdouh F A Mohamed, Gamal El-Din A Abuo-Rahma
Molecular targets and anticancer activity of quinoline-chalcone hybrids: literature review. RSC advances 10 (52) (2020)
Mohamed A A Abdel-Aal, Salah A Abdel-Aziz, Montaser Sh A Shaykoon, Gamal El-Din A Abuo-Rahma
Towards anticancer fluoroquinolones: A review article. Archiv der Pharmazie 352 (7) (2019)
Mahmoud S Abdelbaset, Mohamed Abdel-Aziz, Gamal El-Din A Abuo-Rahma, Mostafa H Abdelrahman, Mohamed Ramadan, Bahaa G M Youssif
Novel quinoline derivatives carrying nitrones/oximes nitric oxide donors: Design, synthesis, antiproliferative and caspase-3 activation activities. Archiv der Pharmazie 352 (1) (2018)
Hend A A Ezelarab, Samar H Abbas, Heba A Hassan, Gamal El-Din A Abuo-Rahma
Recent updates of fluoroquinolones as antibacterial agents. Archiv der Pharmazie 351 (9) (2018)